| Literature DB >> 34062855 |
Chia-Chi Peng1, Tzu-Yin Huang2, Chiung-Yao Huang1, Tsong-Long Hwang3,4,5, Jyh-Horng Sheu1,2,6,7.
Abstract
Two new isosarcophine derivatives, cherbonolides M (1) and N (2), were further isolated from a Formosan soft coral Sarcophyton cherbonnieri. The planar structure and relative configuration of both compounds were established by the detailed analysis of the IR, MS, and 1D and 2D NMR data. Further, the absolute configuration of both compounds was determined by the comparison of CD spectra with that of isosarcophine (3). Notably, cherbonolide N (2) possesses the unique cembranoidal scaffold of tetrahydrooxepane with the 12,17-ether linkage fusing with a γ-lactone. In addition, the assay for cytotoxicity of both new compounds revealed that they showed to be noncytotoxic toward the proliferation of A549, DLD-1, and HuCCT-1 cell lines. Moreover, the anti-inflammatory activities of both metabolites were carried out by measuring the N-formyl-methionyl-leucyl-phenylalanine/cytochalasin B (fMLF/CB)-induced generation of superoxide anion and elastase release in the primary human neutrophils. Cherbonolide N (2) was found to reduce the generation of superoxide anion (20.6 ± 6.8%) and the elastase release (30.1 ± 3.3%) in the fMLF/CB-induced human neutrophils at a concentration of 30 μM.Entities:
Keywords: Sarcophyton cherbonnieri; anti-inflammatory activity; cytotoxicity; isosarcophine derivatives; tetrahydrooxepane
Year: 2021 PMID: 34062855 PMCID: PMC8170881 DOI: 10.3390/md19050260
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Marine natural products 1–3 isolated from the soft coral S. cherbonnieri.
13C and 1H NMR spectroscopic data of 1 and 2.
| Position | 1 α | 1 b | 2 c | |||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| 1 | 162.4 (C) | 159.9 (C) | 166.1 (C) | |||
| 2 | 78.4 (CH) d | 5.64 d (10.4) e | 77.4 (CH) | 4.99 d (10.5) | 79.2 (CH) | 4.93 d (8.4) |
| 3 | 123.4 (CH) | 4.98 d (10.4) | 123.8 (CH) | 4.55 d (10.0) | 120.7 (CH) | 4.50 d (8.4) |
| 4 | 147.5 (C) | 145.5 (C) | 139.2 (C) | |||
| 5 | 77.5 (CH) | 4.21 dd (10.8, 5.2) | 77.3 (CH) | 3.77 dd (10.5, 5.5) | 36.9 (CH2) | 1.66 m; 1.87 m |
| 6 | 33.8 (CH2) | 2.28 m; 2.52 m | 32.8 (CH2) | 2.23 m; 2.31 m | 24.3 (CH2) | 1.77 m; 2.27 m |
| 7 | 122.5 (CH) | 4.98 d (10.8) | 121.4 (CH) | 4.55 d (10.0) | 127.2 (CH) | 4.76 d (10.4) |
| 8 | 134.9 (C) | 134.4 (C) | 133.8 (C) | |||
| 9 | 37.3 (CH2) | 2.08 m; 2.31 m | 36.9 (CH2) | 1.70 m; 1.98 m | 36.1 (CH2) | 1.92 m; 1.94 m |
| 10 | 24.5 (CH2) | 2.07 m; 1.23 m | 24.2 (CH2) | 1.06 m; 1.90 m | 25.8 (CH2) | 0.95 m; 1.98 m |
| 11 | 62.0 (CH) | 2.45, d (10.8) | 61.1 (CH) | 2.28 dd (10.5, 2.5) | 70.7 (CH) | 3.21 dd (10.4, 6.4) |
| 12 | 61.1 (C) | 59.9 (C) | 79.4 (C) | |||
| 13 | 37.8 (CH2) | 2.05 m; 1.04 t (11.2) | 37.3 (CH2) | 0.77 td (13.5, 2.5); 1.61 dd (13.0, 5.5) | 29.4 (CH2) | 1.70 m; 1.97 m |
| 14 | 24.7 (CH2) | 2.02 m; 2.71 m | 23.8 (CH2) | 1.53 d (13.5); 1.95 m | 24.0 (CH2) | 1.66 m; 2.19 m |
| 15 | 123.5 (C) | 123.8 (C) | 128.1 (C) | |||
| 16 | 174.6 (C) | 173.7 (C) | 172.3 (C) | |||
| 17 | 8.6 (CH3) | 1.78 s | 8.7 (CH3) | 1.67 s | 55.9 (CH2) | 4.31 dd (14.8, 1.6); 4.46 d (14.8) |
| 18 | 10.3 (CH3) | 1.74 s | 9.8 (CH3) | 1.33 s | 18.5 (CH3) | 1.27 s |
| 19 | 14.9 (CH3) | 1.72 s | 14.5 (CH3) | 1.31 s | 15.2 (CH3) | 1.36 s |
| 20 | 15.9 (CH3) | 1.28 s | 15.9 (CH3) | 1.02 s | 22.5 (CH3) | 1.02 s |
α 13C and 1H spectroscopic data of 1 recorded at 100 and 400 MHz in acetone-d. b 13C and 1H spectroscopic data of 1 recorded at 125 and 500 MHz in C6D6. c 13C and 1H spectroscopic data of 2 recorded at 100 and 400 MHz in C6D6. d Attached protons were deduced from DEPT experiments. e J values (in Hz) in parentheses.
Figure 2COSY and selective HMBC correlations of 1 and 2.
Figure 3Selective NOE correlations of 1.
Figure 4CD spectrum (1.2 × 10–4 M, MeOH) of 1 and CD spectrum (1.6 × 10–4 M, MeOH) of 3.
Figure 5Selective NOE correlations of 2.
Scheme 1Proposed biosynthetic pathway of cherbonolide N (2).
Figure 6CD spectra (1.2 × 10–4 M, MeOH) of 2.